Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
07/2005
07/06/2005CN1634923A Bibenzil compound 13, 13'-O-iso-propylidene riccardia D and its extraction and separation method and use
07/06/2005CN1634922A Anti-AIDS compound, its preparing method and pharmaceutical composition with anti-AIDS compound as active component and use thereof
07/06/2005CN1634152A Raw material medicine of methylcantharidinimide and its preparation process
07/06/2005CN1634037A Arthritis therapeutic drug
07/06/2005CN1209360C 16-halogen-epothilone derivatives, process for producing them and their pharmaceutical use
07/06/2005CN1209112C Smilagenin and anzurogenin-D for treating Alzheimer's disease
07/05/2005US6914088 Diacetal composition, polyolefin nucleating agent comprising the diacetal composition, polyolefin resin compositions containing the diacetal composition, method for manufacturing the resin composition, and moldings
06/2005
06/30/2005WO2005058841A2 Hiv protease inhibiting compounds
06/30/2005WO2005058820A1 A synthetic methodology for the reductive alkylation at the c-3 position of indoles
06/30/2005WO2005042551B1 Humic acid metallic compound, preparation thereof, compositions containing same and use of said compound
06/30/2005WO2004089926A3 Genipin derivatives and uses thereof
06/30/2005US20050143594 Process for preparing resorcinol derivatives
06/30/2005US20050143429 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
06/30/2005US20050143327 Used to ameliorate oxidative stress diseases eg neurodegenerative diseases
06/30/2005US20050142542 Absobers materials used for removal or reduction of microbiocides from body fluids such as blood; filtration
06/30/2005US20050139814 Benzofuran and benzothiophene derivatives useful in the treatmint of hyper-proliferative disorders
06/30/2005CA2549860A1 Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
06/30/2005CA2549098A1 Hiv protease inhibiting compounds
06/29/2005EP1546153A1 Broadspectrum substituted oxindole sulfonamide hiv protease inhibitors
06/29/2005EP1546152A1 Epothilone derivatives
06/29/2005EP1545550A2 Isosorbide mononitrate compositions and methods of their use
06/29/2005EP1545518A1 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
06/29/2005EP1545502A2 Keto cannabinoids with therapeutic indications
06/29/2005CN1631879A Substituted phenyl keto enols as pesticides and herbicides
06/29/2005CN1208828C Erase method for non-volatile memory
06/29/2005CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
06/29/2005CN1208056C Medicine containing Anemonin as effective component for treating aseptic inflammation
06/23/2005WO2005057207A1 Trityl derivatives for enhancing mass spectrometry
06/23/2005WO2005056549A1 Water-soluble etoposide analogs and methods of use thereof
06/23/2005WO2005023792A3 Macrocyclic compounds useful as pharmaceuticals
06/23/2005US20050137237 Triazolo-epothilones
06/23/2005US20050137215 Antiarthritic and antiinflammatory agents; analgesics; the proline derivatives do not displace gabapentin from alpha-2-delta receptors
06/23/2005US20050137211 Phenyl-piperazine derivatives as modulators of muscarinic receptors
06/23/2005US20050136503 Fluorescent pH indicators for intracellular assays
06/23/2005US20050136136 Method for isolating terpene trilactones (ginkgolides, bilobadide) from leaves and pharmaceutical powders of ginkgo biloba
06/22/2005EP1542998A2 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b
06/22/2005CN1630653A Pyrazolyl-substituted heterocycles and their use as phytosanitary products
06/22/2005CN1629164A Chiral pharmaceutical intermediate and its synthesis method and use
06/21/2005CA2180010C 7-¬carboxyalkyl or alkenyl|-6-¬alkyl or alkenyl| 3-oxo-2,4-dioxobicyclo-¬3.2.1| octane and derivatives thereof
06/21/2005CA2147423C Preparation process of ginkgolide b from ginkgolide c
06/16/2005WO2005054336A1 Pellicle and novel fluorinated polymer
06/16/2005WO2005054251A1 New cartharidic amine, demethyl cartharidic amine derivatives and their medicinal use
06/16/2005WO2005054250A1 Tricyclacetalactonin, Preparation and Use there of
06/16/2005WO2005054170A1 Remedy
06/16/2005WO2005028481A3 Fused pentacyclic polyethers
06/16/2005WO2004002428A3 Derivatives of gambogic acid and induce apoptosis
06/16/2005US20050131061 Angiogenesis inhibitors
06/16/2005US20050131060 Spirolaxine acts as active principle for treatment of those pathologies responding to activation of PPAR gamma receptor, such as acute malignant haemopathies. and Type 2 insulin-resistant diabetes
06/16/2005US20050131042 HIV protease inhibiting compounds
06/16/2005US20050131017 HIV protease inhibiting compounds
06/16/2005US20050130314 Diaminofluorescein derivatives
06/15/2005EP1541558A1 Heterocyclic compound having hiv integrase inhibitory activity
06/15/2005EP1539962A1 Polyene polyketides and methods of production
06/15/2005EP1539768A2 A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same
06/15/2005EP1539741A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
06/15/2005EP1539729A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/15/2005EP1539717A2 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives
06/15/2005EP1539690A2 Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography
06/15/2005EP1539134A2 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
06/15/2005CN1628117A Biocidal compounds and their preparation
06/15/2005CN1627942A Process for isolating srtemisinin from artemisia annua
06/15/2005CN1626536A Method of purifying moxidectin through crystallization
06/15/2005CN1626534A Steroid receptor modulator compounds and methods
06/15/2005CN1205927C Water soluble trioxanes as potent and safe anti-malarial agents
06/14/2005US6906207 Nucleating agents for improving the optical properties; for food or cosmetic containers and packaging; as gelling agents for water and organic solvents used in the preparation of antiperspirant gel sticks
06/14/2005US6906206 Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
06/14/2005US6906205 Spiro and dispiro 1,2,4-trioxolane antimalarials
06/14/2005US6906203 Anticancer agents; such as 2-Amino-3-cyano-4-(2-bromo-4,5-dimethoxyphenyl)-4H-indolo(4,5-b)pyran
06/14/2005US6906101 Taxane derivatives and processes for the preparation thereof
06/09/2005WO2005051956A1 Brevetoxin derivative, process for producing the same and method of detecting shellfish neurotoxin using the same
06/09/2005WO2005051955A1 Novel compound and medicinal composition
06/09/2005WO2005051376A1 Medicaments containing collybolides
06/09/2005WO2004080410A3 Furanose-type bicyclic carbohydrates with biological activity
06/09/2005US20050124686 Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases
06/09/2005US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy
06/09/2005US20050124658 Decahydronaphtho[2,3-c]furan derivatives
06/09/2005US20050123478 Agent for measurement of singlet oxygen
06/09/2005DE10353300A1 Polyzyklische Makrolactone Polycyclic macrolactones
06/08/2005EP1538150A1 Novel pleuromutilin derivatives
06/08/2005EP1537123A1 Compounds
06/08/2005CN1623994A New compound
06/08/2005CN1623993A Cantharides amine and demethyl cantharides amine derivative and application in medicine thereof
06/08/2005CN1623543A Organic compounds
06/08/2005CN1205208C C-21 modified epothilones
06/07/2005US6903226 Comprises xanthene-containing zinc complexes; for diagnosis of Alzheimer's disease
06/07/2005US6902687 Optically active isosorbide derivative and optically active isomannide derivative, production methods thereof, photo-reactive chiral agent, liquid crystal composition, liquid crystal color filter, optical film and recording medium, method for changing helical structure of liquid crystal and method for fixing helical structure of liquid crystal
06/02/2005WO2005049582A1 Method of preparation of novel nucleoside analogs and uses
06/02/2005WO2005048921A2 Bicyclic carbohydrates for the treatment of infections caused by the alphaherpesvirinae hsv-1 and hsv-2
06/02/2005US20050119338 Combination of cytochome p450 dependent protease inhibitors
06/02/2005US20050119336 Synthesis of derivatives of ginkgolide C
06/02/2005US20050119334 Neurodegenerative disease; Alzheimer's and Parkinson's disease
06/02/2005US20050119232 10 alpha -(sulfamino)dihydroartemisinin and Bis[(10 alpha -dihydroartemisinyl)]sulfamide; parasiticide; malaria, neosporosis and coccidiosis; Plasmodium falciparum, Neospora caninum and Eimeria tenella; improved stability, bioavailability, neurotoxicity
06/02/2005DE10351274A1 Metallverbindung von Huminsäuren, deren Herstellung, Zusammensetzungen, die diese enthalten und Verwendung derselben Metal compound of humic acids, their preparation, compositions containing them and use thereof
06/01/2005EP1534678A1 Pleuromutilin derivatives as antimicrobbials
06/01/2005EP1534255A2 Processes for preparing 1,3-dioxolane nucleosides
06/01/2005EP1351959B1 Novel pleuromutilin derivatives
05/2005
05/31/2005US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis
05/31/2005US6900339 Collecting bryostatin from a plankton larvae, by stressing, exudation, isolation, extraction, purification; use as antitumor agents, anticarcinogenic agents, leukemia
05/31/2005US6900331 Derivatives of epothilone B and D and synthesis thereof
05/31/2005US6900160 Triazolo-epothilones
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 174